| Frederick Wright, MD | |
|
2999 Regent St, Suite 622, Berkeley, CA 94705-2146 | |
| (510) 883-9292 | |
| Not Available |
| Full Name | Frederick Wright |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 36 Years |
| Location | 2999 Regent St, Berkeley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255377370 | NPI | - | NPPES |
| 00G683531 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | G68353 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital-san Jose | San jose, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
A mathematical model developed by Robert Brown, Texas A&M professor of landscape architecture, was used in a highly publicized study quantifying the time it takes for young children to become dangerously hot when they are accidentally left in the back seat of a sweltering car.
The risk factors for stroke and dementia are the same, and a growing body of evidence demonstrates that preventing stroke can also prevent some dementias.
A new report showing "research funding for four key HIV prevention options - preventive vaccines, microbicides, PrEP and operations research related to medical male circumcision" - increased in 2010 compared with 2009 "is certainly good news, but we cannot rest on our laurels," Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative, Zeda Rosenberg, CEO of the International Partnership for Microbicides, and Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, write in a post on the Global Health Magazine's blog.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Researchers at Johns Hopkins have discovered that the Notch protein helps human embryonic stem cells 'decide' their own fate, a finding which may eventually be useful in programming cells for the development of stem cell therapies. Their results are reported in the May 2008 issue of Cell Stem Cell.
› Verified 6 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
A mathematical model developed by Robert Brown, Texas A&M professor of landscape architecture, was used in a highly publicized study quantifying the time it takes for young children to become dangerously hot when they are accidentally left in the back seat of a sweltering car.
The risk factors for stroke and dementia are the same, and a growing body of evidence demonstrates that preventing stroke can also prevent some dementias.
A new report showing "research funding for four key HIV prevention options - preventive vaccines, microbicides, PrEP and operations research related to medical male circumcision" - increased in 2010 compared with 2009 "is certainly good news, but we cannot rest on our laurels," Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative, Zeda Rosenberg, CEO of the International Partnership for Microbicides, and Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, write in a post on the Global Health Magazine's blog.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Researchers at Johns Hopkins have discovered that the Notch protein helps human embryonic stem cells 'decide' their own fate, a finding which may eventually be useful in programming cells for the development of stem cell therapies. Their results are reported in the May 2008 issue of Cell Stem Cell.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frederick Wright, MD 729 Spruce St, Berkeley, CA 94707-2040 Ph: (540) 526-8518 | Frederick Wright, MD 2999 Regent St, Suite 622, Berkeley, CA 94705-2146 Ph: (510) 883-9292 |
News Archive
A mathematical model developed by Robert Brown, Texas A&M professor of landscape architecture, was used in a highly publicized study quantifying the time it takes for young children to become dangerously hot when they are accidentally left in the back seat of a sweltering car.
The risk factors for stroke and dementia are the same, and a growing body of evidence demonstrates that preventing stroke can also prevent some dementias.
A new report showing "research funding for four key HIV prevention options - preventive vaccines, microbicides, PrEP and operations research related to medical male circumcision" - increased in 2010 compared with 2009 "is certainly good news, but we cannot rest on our laurels," Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative, Zeda Rosenberg, CEO of the International Partnership for Microbicides, and Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, write in a post on the Global Health Magazine's blog.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Researchers at Johns Hopkins have discovered that the Notch protein helps human embryonic stem cells 'decide' their own fate, a finding which may eventually be useful in programming cells for the development of stem cell therapies. Their results are reported in the May 2008 issue of Cell Stem Cell.
› Verified 6 days ago
Bruce James Rice, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2316 Dwight Way, Berkeley, CA 94704 Phone: 510-845-4500 Fax: 510-845-0360 | |
Dr. Calvin Boyd Benton, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3031 Telegraph Ave, Suite 217, Berkeley, CA 94705 Phone: 510-981-8222 Fax: 510-568-8848 | |
Rita Ophelia Kwan-feinberg, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2850 Telegraph Ave, Suite 120, Berkeley, CA 94705 Phone: 510-204-8120 | |
Kieran Melody, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2704 8th St, Berkeley, CA 94710 Phone: 510-381-4542 | |
Jeffrey Stern, Surgery Medicare: May Accept Medicare Assignments Practice Location: 2001 Dwight Way, 2nd Floor, Berkeley, CA 94704 Phone: 510-204-5745 Fax: 510-504-5749 | |
Kristine A. Steensma, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2793 Benvenue Ave, Berkeley, CA 94705 Phone: 510-843-6735 |